IC
CNTB

Ikarian Capital’s Connect Biopharma Holdings CNTB Stock Holding History

Ikarian Capital’s Portfolio CNTB Stock Details CNTB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$379K Hold
144,600
– – 0.03% 131
2025
Q4 		$408K Buy
+144,600
New +$308K 0.03% 141

Other funds holding CNTB

BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
RB
Richmond Brothers Jackson, Michigan $150M AUM 14.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return
DMKJ
David M. Knott Jr $168M AUM 60.36% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Ikarian Capital's CNTB Position: Q1 2026 in Review

Ikarian Capital increased its Connect Biopharma Holdings (CNTB) stake by 13% in Q1 2026, buying an estimated $1.56M and bringing the position to 5,388,486 shares worth $13.1M. The position accounts for 1.07% of the portfolio, ranked #23.

Ikarian Capital first reported a position in CNTB in Q4 2021 and has held it in 9 quarters since. The position peaked at $13.5M in Q4 2025. 41 funds tracked by Wall St. Rank hold CNTB as of Q1 2026.

  • Ikarian Capital held 5,388,486 shares of Connect Biopharma Holdings worth $13.1M as of Q1 2026.
  • Ikarian Capital bought 600,000 Connect Biopharma Holdings shares in Q1 2026, an estimated $1.56M.
  • Connect Biopharma Holdings made up 1.07% of Ikarian Capital's portfolio in Q1 2026, its #23 holding.
  • Ikarian Capital first reported a position in Connect Biopharma Holdings in Q4 2021 and has held it in 9 quarters since.
  • Ikarian Capital's Connect Biopharma Holdings position peaked at $13.5M in Q4 2025.
  • 41 funds tracked by Wall St. Rank held Connect Biopharma Holdings as of Q1 2026.

Based on Ikarian Capital's 13F filing for Q1 2026, filed 15 May 2026.